The underlying causes, clinical presentation, assessment, management and treatment of acute kidney injury are discussed in this third article in a series about the renal system. Abstract This is the ...

Acute kidney injury, acute kidney diseases and disorders, and chronic kidney disease are discussed in this second article in a series about the renal system. Abstract This article, the second in a ...

The Paradise uRDN system received U.S. Food and Drug Administration (FDA) approval on November 7, 2023, as a first-of-its-kind ultrasound-based renal denervation technology designed to lower blood ...

The US Food and Drug Administration (FDA) has approved Medtronic's Symplicity Spyral renal denervation system for the treatment of hypertension, the company has announced. The Symplicity Spyral system ...

The US Food and Drug Administration has approved the ultrasound-based Paradise renal denervation system for the treatment of hypertension, marking the culmination of more than a decade of work—with ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The latest edition of the United States Renal Data ...

On Wednesday, the FDA's Circulatory System Devices Panel voted 6-7 (with one abstention) that the benefits of the Symplicity Spyral multi-electrode catheter system do not outweigh its risks when used ...

Credit: Medtronic. The Simplicity Spyral RDN system is designed to lower BP by delivering radiofrequency energy through the wall of the renal artery to denervate the kidney from sympathetic nerve ...